Inventor
CAROFF EVA
FR14 patents
⚠️ This page may combine multiple inventors who share the name “CAROFF EVA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAROFF EVA
6 patentsUS8518912B2Aug 27, 2013
Phosphonic acid derivates and their use as P2Y12 receptor antagonists
CAROFF EVA9 citations82
US8288385B2Oct 16, 2012
6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
CAROFF EVA7 citations82
US8058263B2Nov 15, 2011
Substituted 2-phenyl-pyridine derivatives
CAROFF EVA9 citations82
US8664203B2Mar 4, 2014
Thiazole derivatives and their use as P2Y12 receptor antagonists
CAROFF EVA4 citations71
US8466156B2Jun 18, 2013
2-phenyl-4-cyclopropyl-pyrimidine derivatives
CAROFF EVA5 citations71
US8093250B2Jan 10, 2012
2-aminocarbonyl-pyridine derivatives
CAROFF EVA5 citations56
ACTELION PHARMACEUTICALS LTD
4 patentsUS8048881B2Nov 1, 2011
Pyrimidine derivatives and their use as P2Y12 receptor antagonists
ACTELION PHARMACEUTICALS LTD9 citations82
US9266876B2Feb 23, 2016
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
ACTELION PHARMACEUTICALS LTD5 citations67
US8044055B2Oct 25, 2011
2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor
ACTELION PHARMACEUTICALS LTD5 citations61
US7727979B2Jun 1, 2010
Guanidine derivatives and their use as neuropeptide FF receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations48
IDORSIA PHARMACEUTICALS LTD
4 patentsUS10047080B2Aug 14, 2018
(R)-2-methyl-piperazine derivatives as CXCR3 receptor modulators
IDORSIA PHARMACEUTICALS LTD1 citations50
US10259807B2Apr 16, 2019
1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
IDORSIA PHARMACEUTICALS LTD0 citations40
US10053457B2Aug 21, 2018
Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations40
US9951063B2Apr 24, 2018
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives
IDORSIA PHARMACEUTICALS LTD0 citations34